Sékouba Sidimé/LinkedIn
Jun 2, 2026, 19:42
Sékouba Sidimé: vWD vs Hemophilia A – The Classic USMLE Step 1 trap in Hematology
Sékouba Sidimé, Internal Medicine Physician, shared a post on LinkedIn:
“vWD vs Hemophilia A – The No. 1 USMLE Step 1 trap in Hematology
One lab result tells them apart.Here’s what you need to know:
von Willebrand Disease
- Prolonged aPTT, prolonged Bleeding time, decreased Ristocetin
- Female with a family history and mucocutaneous bleeding
- Treatment: Desmopressin (DDAVP)
Hemophilia A
- Prolonged aPTT , Bleeding time normal, Ristocetin normal
- Male with hemarthroses
- Treatment: Factor VIII replacement
The key:
vWF carries Factor VIII — decreased vWF results in secondary reduction of Factor VIII.
That’s why vWD affects both aPTT AND bleeding time.
Hemophilia A affects aPTT only.
If the examiner mentions Ristocetin then think vWD. Every time.”
Stay updated with Hemostasis Today.
-
Jun 2, 2026, 19:41Bassem M. Mohammed: How Factor VIII Interacts To Procoagulant Membranes To Support Activation Of Blood Clotting
-
Jun 2, 2026, 19:28Looking Beyond Bleeding Control To Understand Inflammation In Hemophilic Arthropathy – CRH French Reference Center for Hemophilia Lyon
-
Jun 2, 2026, 19:27Francisco Chacón-Lozsán: Coma Is Not a Diagnosis – Final Pathway Of Brain Arousal And Awareness Failure
-
Jun 2, 2026, 19:26Panagiotis Papanagiotou: Recognizing CVST On T2 MRI
-
Jun 2, 2026, 17:56Coralie Delporte Gravouil: Scientific Program 2026 – Essentials of Hemostasis Now Available
-
Jun 2, 2026, 17:55Anna Rivera: Hemophilia Management – A Shift from Traditional IV Therapies to Novel Subcutaneous Agents
-
Jun 2, 2026, 17:53Zoya Surayya: My Thesis on Anticoagulation After Ischemic Stroke
-
Jun 2, 2026, 17:49Jeffrey Hall: A Pivotal Moment to Protect Rhode Island Wildlife from Anticoagulant Rodenticides
-
Jun 2, 2026, 17:47Nathan Connell: Connecting History with the Future of VWD Care